FMS
Fresenius Medical CareDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Bull: Successful margin recovery, stable dialysis volumes, and positive reimbursement developments drive recovery to multi-year highs as investors re-rate growth stability.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
ADR liquidity and FX/ADR ratio dynamics
Momentum
34
Value
71
Sentiment
15
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.39 · Bull $4.00 · Bear $2.46
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-09-30 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $26.01
Why
Momentum34 · Δ7d -0.4
Value71 · Δ7d +0.1
Sentiment15 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
34
34% active weight
Current posture
7d trendSoftening
Δ7d
-0.4
Δ21d
+3.6
Value
71
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+1.0
Sentiment
15
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 34.4 / Value 71.0 / Sentiment 14.7
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$11.25B
Beta
1.06
Shares Out
289.85M
P/E (TTM)
16.5
P/S (TTM)
0.60
P/FCF (TTM)
6.77
Rev YoY
+2.6%
EPS YoY
+29.6%
Gross Margin
+25.0%
Op Margin
+7.6%
Net Debt
$10.27B
Current Ratio
1.36
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology